NCT01848925 Study of SANGUINATE™ Versus Hydroxyurea in Sickle Cell Disease (SCD) Patients Status COMPLETED Phase PHASE1
NCT01835496 Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT01800526 A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01794000 A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) Status TERMINATED Phase PHASE3
NCT01783691 Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD) Status COMPLETED Phase PHASE1
NCT01771731 Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01757418 Intravenous Gammaglobulin for Sickle Cell Pain Crises Status COMPLETED Phase PHASE1/PHASE2
NCT01737814 Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC) Status COMPLETED Phase PHASE3
NCT01736657 Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients Status COMPLETED Phase NA
NCT01732718 Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT01718054 Vascular Function Intervention Trial in Sickle Cell Disease Status UNKNOWN Phase PHASE2/PHASE3
NCT01702246 Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01685515 Study of Decitabine and Tetrahydrouridine (THU) in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT01673243 Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting Status COMPLETED Phase N/A
NCT01603160 Improving Emergency Department Management of Adults With Sickle Cell Disease Status COMPLETED Phase N/A